Peer-reviewedCC BY-NC-NDJournal of thoracic disease
Central nervous system efficacy of third generation vs. first generation EGFR-TKIs in the first line treatment for EGFR-mutated non-small cell lung cancer with central nervous system metastases: a systematic review and meta-analysis of phase 3 randomized controlled trials
- 1Department of Oncology , The Second Affiliated Hospital , Jiangxi Medical College , Nanchang University , Nanchang , ;
- 2Department of General Surgery , The Second Affiliated Hospital , Jiangxi Medical College , Nanchang University , Nanchang ,
Related
- Topical herbal medicine as treatment for chemotherapy-induced peripheral neuropathy: a systematic review of randomized controlled trials
- A Comparative Analysis of Surgical Treatment for First Carpometacarpal Osteoarthritis: A Systematic Review and Pooled Analysis of Randomized Controlled Trials
- Efficacy and safety of adipose tissue-derived cell therapy in the treatment of chronic extremity ulcers: a systematic review and meta-analysis of randomized controlled trials
- Pain‐Related Outcome Domains and Measures in Randomized Controlled Trials of Treatment for Acute Abdominal Pain: A Systematic Review
- Efficacy and safety of Limosilactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis in children: a systematic review and meta-analysis of randomized controlled trials
BibTeX
@article{gan2026central,
title = {{Central nervous system efficacy of third generation vs. first generation EGFR-TKIs in the first line treatment for EGFR-mutated non-small cell lung cancer with central nervous system metastases: a systematic review and meta-analysis of phase 3 randomized controlled trials}},
author = {Jiongli Gan and Shaofeng Zhu and Yan Fang and Jiaqiang Wang and Tiande Liu and Jing Cai},
journal = {Journal of thoracic disease},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13655810},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Central nervous system efficacy of third generation vs. first generation EGFR-TKIs in the first line treatment for EGFR-mutated non-small cell lung cancer with central nervous system metastases: a systematic review and meta-analysis of phase 3 randomized controlled trials
AU - Jiongli Gan
AU - Shaofeng Zhu
AU - Yan Fang
AU - Jiaqiang Wang
AU - Tiande Liu
AU - Jing Cai
PY - 2026
DA - 2026/09/23
JO - Journal of thoracic disease
UR - https://europepmc.org/article/PMC/PMC13655810
SN - 2072-1439
SN - 2077-6624
ER -